The report recognizes the following companies as the key players in Global Next Generation Sequencing Market 2015-2019: Illumina, Roche Diagnostics and Thermo Fischer Scientific
Other Prominent Vendors in the market are: 10X Genomic, 23andMe, Ambry Genetics, Axeq Technologies, Beijing Genomics Institute, CLC bio, Clontech Laboratories, Fluidigm, Foundation Medicine, GATC Biotech, GeneDx, GENEWIZ, Gnomegen, Good Start Genetics, Ingenuity Systems, Knome, NABsys, Oxford Nanopore Technologies, Pathogenica, PerkinElmer, RainDance Technologies, Rubicon Genomics, Sequenom, Sigma-Aldrich, Source Biosciences and Takara Bio
Commenting on the report, an analyst from Technavio’s team said: “One of the major trend in this market is strategic alliances between large corporations and specialized companies for enhancing their business in genomic sequencing. For instance, in 2014 Thermo Fisher Scientific collaborated with Pfizer and GSK to develop oncology companion diagnostics using NGS technology. These alliances enhance the expertise in DNA sequencing and accelerate drug discovery efforts.”
According to the report, one of the major factors expected to drive the market is advances in applications of NGS in molecular biology and biomedical engineering. The evolution of NGS technology as a molecular microscope has created interest among researchers, hospitals, and pharmaceutical and life sciences companies in finding solutions for complex biological questions.
Further, the report states that one of the challenge is the lack of standardization in data analysis.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.